{"schema_version":"secwatch.filing_event.v1","accession":"0001161697-26-000051","form_type":"8-K","ticker":"KRMD","cik":"0000704440","company_name":"KORU Medical Systems, Inc.","filed_at":"2026-03-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:37.497281+00:00","generated_at":"2026-05-15T14:27:37.615742+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"KORU Medical reports 22% FY2025 revenue growth; positive adjusted EBITDA; initiates FY2026 guidance","bullets":["Q4 2025 net revenue $10.9M (+23% YoY); FY2025 net revenue $41.1M (+22% YoY).","International Core revenue grew 80% in FY2025; Domestic Core grew 11%.","FY2025 net loss narrowed 57% to $2.6M ($0.06 loss per share); positive adjusted EBITDA of $0.6M.","Cash and cash equivalents $8.9M at Dec 31, 2025; used only $0.7M cash in FY2025.","FY2026 guidance: net revenue $47.5–$50.0M (15–22% growth); positive adjusted EBITDA and positive cash flow."],"urls":{"canonical":"https://secwatch.observer/filing/0001161697-26-000051","json":"https://secwatch.observer/filing/0001161697-26-000051.json","markdown":"https://secwatch.observer/filing/0001161697-26-000051.md","text":"https://secwatch.observer/filing/0001161697-26-000051.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/704440/000116169726000051/0001161697-26-000051-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/704440/000116169726000051/form_8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T14:27:37.615742+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}